Similarly, at a lower dose, injection of AAV-IL-27 into established J558 tumors resulted in a slight inhibition of tumor growth (Figure 2D), while at a high dose, mice had nearly complete tumor rejection (Figure 2E) with long term tumor free survival (Figure 2F). This evidence concerns the gene IL27 and neoplasm.